Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze LMAT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate LMAT investment potential.

What is LMAT stock price today?

Get real-time LMAT stock price, historical data, and price charts on Financhill. Track LMAT performance with our advanced analysis tools.

Is LMAT a good investment?

Evaluate LMAT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy LMAT stock?

To buy LMAT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of LMAT?

View detailed market capitalization data and company valuation metrics for LMAT on our comprehensive analysis page.

What is the P/E ratio of LMAT?

Use our fundamental analysis tools to view LMAT P/E ratio and compare valuation metrics with industry peers.

What are LMAT earnings?

View LMAT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

LeMaitre Vascular, Inc. 10K Form

Buy

LMAT
LeMaitre Vascular, Inc.

Last Price:

$85.70

Seasonality Move:

1.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10	10Q	LMAT/LeMaitre Vascular, Inc. Quarterly
2023-11-07	10Q	LMAT/LeMaitre Vascular, Inc. Quarterly
2023-08-08	10Q	LMAT/LeMaitre Vascular, Inc. Quarterly
2023-05-09	10Q	LMAT/LeMaitre Vascular, Inc. Quarterly
2022-11-08	10Q	LMAT/LeMaitre Vascular, Inc. Quarterly
2022-08-05	10Q	LMAT/LeMaitre Vascular, Inc. Quarterly

Receive LMAT News And Ratings

See the #1 stock for the next 7 days that we like better than LMAT

LMAT Financial Statistics

Sales & Book Value

Annual Sales:	$219.9M
Cash Flow:	$26.5M
Price / Cash Flow:	30.11
Annual Sales:	$16.71
Price / Book:	5.13

Profitability

EPS (TTM):	2.32380
Net Income (TTM):	$53.3M
Gross Margin:	$145.1M
Return on Equity:	15.17%
Return on Assets:	10.02%

LeMaitre Vascular, Inc. Earnings Forecast

Key LeMaitre Vascular, Inc. Financial Ratios

The Gross Profit Margin over the past 24 years for LMAT is 66.00%.
The Selling, General & Administrative Expenses for LMAT have been equal to 37.75% of Gross Profit Margin.
The Research & Development expenses have been 7.12% of Revenue.
The Interest Expense is 0.47% of Operating Income.
The Net Earning history of LMAT is 20.03% of Total Revenues.
Per Share Earnings over the last 24 years have been positive in 15 years.

LeMaitre Vascular, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Health Care Equipment & Supplies
Sector:	Health Care
Current Symbol:	LMAT
CUSIP:	525558
Website:	lemaitre.com

Debt

Debt-to-Equity Ratio:	0.49
Current Ratio:	13.22
Quick Ratio:	11.32

Price-to-Earnings

Trailing P/E Ratio:	44.33
Forward P/E Ratio:	33.11

LMAT Technical Analysis vs Fundamental Analysis

Buy

LeMaitre Vascular, Inc. (LMAT) is a Buy

Is LeMaitre Vascular, Inc. a Buy or a Sell?

LeMaitre Vascular, Inc. stock is rated a Buy

The current LeMaitre Vascular, Inc. [LMAT] share price is $85.70. The Score for LMAT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.